Related Experiment Video
Updated: May 29, 2026
11:47
A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
RNA therapeutics targeting osteoclast-mediated excessive bone resorption
1Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT 84112-5820, USA. luckwangyuwei@gmail.com
Advanced Drug Delivery Reviews
|September 28, 2011
Summary
RNA interference (RNAi) offers a novel therapeutic strategy for osteoporosis by silencing genes in osteoclasts. This approach targets excessive bone resorption, addressing a growing global healthcare challenge.
Area of Science:
- Molecular Biology
- Biotechnology
- Genetics
Background:
- Osteoporosis is a growing global health concern, characterized by fragility fractures due to excessive bone resorption.
- Current osteoporosis treatments are insufficient for the increasing patient population.
- RNA interference (RNAi) is a powerful gene silencing technique with therapeutic potential.
Purpose of the Study:
- To review molecular targets for RNAi-based gene knockdown in osteoclasts.
- To explore strategies for targeted siRNA delivery and gene silencing.
- To discuss the opportunities and challenges of using siRNA for hard and connective tissue disorders.
Main Methods:
- Literature review of RNA interference mechanisms and applications.
- Analysis of molecular targets within osteoclasts relevant to bone resorption.
- Evaluation of siRNA delivery systems and gene silencing efficiencies.
- Assessment of therapeutic potential in hard and connective tissue disorders.
Main Results:
- Identified diverse molecular targets in osteoclasts suitable for RNAi-mediated gene knockdown.
- Outlined strategies for developing targeted siRNA delivery systems.
- Described methods for achieving efficient gene silencing in osteoclasts.
- Highlighted the potential of siRNA as a therapeutic agent for osteoporosis.
Conclusions:
- RNAi targeting osteoclast function presents a promising therapeutic avenue for osteoporosis.
- Effective siRNA delivery and gene silencing are key to successful therapeutic application.
- Further research is needed to overcome challenges in translating siRNA to clinical practice for bone disorders.
Related Concept Videos
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...